Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Byhealth Co stock

300146.SZ
CNE100000Y84

Price

12.89
Today +/-
+0.02
Today %
+0.94 %
P

Byhealth Co stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Byhealth Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Byhealth Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Byhealth Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Byhealth Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Byhealth Co Stock Price History

DateByhealth Co Price
11/19/202412.89 undefined
11/18/202412.77 undefined
11/15/202412.90 undefined
11/14/202413.00 undefined
11/13/202413.52 undefined
11/12/202413.57 undefined
11/11/202413.62 undefined
11/8/202413.64 undefined
11/7/202413.89 undefined
11/6/202413.20 undefined
11/5/202413.26 undefined
11/4/202412.80 undefined
11/1/202412.62 undefined
10/31/202412.74 undefined
10/30/202412.70 undefined
10/29/202412.74 undefined
10/28/202413.06 undefined
10/25/202413.47 undefined
10/24/202413.54 undefined
10/23/202413.10 undefined
10/22/202413.18 undefined

Byhealth Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Byhealth Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Byhealth Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Byhealth Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Byhealth Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Byhealth Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Byhealth Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Byhealth Co’s growth potential.

Byhealth Co Revenue, EBIT and net profit per share

DateByhealth Co RevenueByhealth Co EBITByhealth Co Net Income
2026e9.19 B undefined1.74 B undefined994.85 M undefined
2025e8.35 B undefined1.99 B undefined858.68 M undefined
2024e7.6 B undefined1.69 B undefined653.66 M undefined
20239.41 B undefined1.98 B undefined1.75 B undefined
20227.86 B undefined1.66 B undefined1.39 B undefined
20217.43 B undefined1.89 B undefined1.75 B undefined
20206.09 B undefined1.4 B undefined1.52 B undefined
20195.26 B undefined1.2 B undefined-358.4 M undefined
20184.35 B undefined1.09 B undefined999.3 M undefined
20173.11 B undefined759 M undefined762.8 M undefined
20162.31 B undefined557.1 M undefined535.2 M undefined
20152.27 B undefined637.5 M undefined635.5 M undefined
20141.71 B undefined510.4 M undefined502.6 M undefined
20131.48 B undefined468.6 M undefined421.7 M undefined
20121.07 B undefined295.6 M undefined280.4 M undefined
2011658 M undefined182.2 M undefined186.4 M undefined
2010346.1 M undefined106.3 M undefined92.1 M undefined
2009205.3 M undefined61.6 M undefined52.2 M undefined
2008141.9 M undefined36.3 M undefined26.7 M undefined
200766.9 M undefined17.2 M undefined12.1 M undefined

Byhealth Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0.070.140.210.350.661.071.481.712.272.313.114.355.266.097.437.869.417.68.359.19
-113.6445.3968.7890.1762.0139.0215.0532.901.9034.6939.8720.9415.8321.945.7919.65-19.249.9010.10
54.5559.5761.9563.2962.9263.3264.6464.8766.1564.1066.9567.2065.3762.6765.8168.1268.7685.1577.4870.37
0.040.080.130.220.410.680.961.111.51.482.082.923.443.824.895.366.47000
0.010.030.050.090.190.280.420.50.640.540.761-0.361.521.751.391.750.650.860.99
-116.67100.0076.92102.1750.5450.3619.2426.49-15.7542.4331.10-135.84-525.7015.09-21.0426.06-62.6031.3915.85
--------------------
--------------------
0.030.720.870.981.311.311.311.321.431.461.471.461.511.581.671.711.7000
--------------------
Details

Keystats

Revenue and Growth

The Byhealth Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Byhealth Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20072008200920102011201220132014201520162017201820192020202120222023
                                 
0.010.020.041.51.351.251.531.542.672.672.952.672.511.873.145.636.44
48813223740435254154221114164290330.34249.12
20153550326067112114139114227123147.53348.3
15173367114210234229309339422671742873833898.91989.07
00.010.010.090.10.080.020.040.030.060.420.40.331.722.950.30.29
0.040.050.091.681.621.621.861.913.143.234.064.13.814.857.347.38.31
0.010.020.050.070.260.40.480.580.70.720.670.720.950.981.181.252.49
00000000.050.871.131.081.091.281.331.382.432.13
00000000000000023.480
0000.010.010.030.10.10.170.230.221.60.90.950.820.760.7
000000000002.171.181.221.121.141.17
00.010.010.010.010.060.020.060.040.020.080.120.20.321.130.260.29
0.010.030.060.080.280.490.60.791.772.12.065.74.524.795.635.886.79
0.040.080.151.761.892.112.462.74.915.336.119.798.339.6412.9713.1815.1
                                 
00.030.040.060.110.220.330.660.731.471.471.471.581.581.71.71.7
0.010.010.011.421.371.261.160.872.641.992.032.023.213.26.176.116.12
0.0100.060.150.280.450.740.921.191.291.672.191.162.122.82.994.42
0000000072010-376536-128-48.0419.07
00000000000000-56-57.58-73.41
0.020.040.111.631.761.932.232.454.564.775.185.646.026.9310.4910.6912.18
889203248676779185275339339350408366.92426.57
1237163253399065173270139255247266.87358.92
0.010.020.020.030.090.090.090.140.170.350.460.721.031.531.381.471.66
0912700100050158430000
0000000000002091033320.3412.71
0.020.040.040.130.130.170.210.240.340.610.911.491.762.242.072.122.46
00000000000893308144413.92161.46
000044266911407224218221189.6153.44
00001464111058112111999685.4877.65
00000.010.010.010.010.020.020.071.410.640.460.360.280.39
0.020.040.040.130.140.180.220.250.350.630.982.92.42.72.432.42.86
0.050.080.151.751.892.12.462.74.915.46.168.558.429.6312.9213.0915.04
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Byhealth Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Byhealth Co's financial health and stability.

Assets

Byhealth Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Byhealth Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Byhealth Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Byhealth Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2007200820092010201120122013201420152016201720182019202020212022
0000000000000001.39
000000000000000229
000000000000000-63
-6-39-48-100-149-409-370-453-717-843-1,059-1,401-2,155-2,359-3,048-3,769
00000000000000043
0000000000000000
-5-24-34-54-92-143-254-306-388-443-537-740-681-947-978-953
0.010.030.040.050.170.110.630.560.630.680.951.351.541.571.821.38
-3-15-32-78-190-158-168-196-269-150-153-250-331-321-263-244
-6-20-32-78-200-169-171-236-2,21323676-4,041-249-531-2,353-131
-2-500-10-10-3-39-1,944386230-3,79082-210-2,090113
0000000000000000
09358-70000000949-490-313-2460
0000000000000000
00.010.011.49-0.13-0.11-0.13-0.291.48-0.35-0.381.74-1.27-0.951.64-1.23
000.011.43-0000.041.850.101.30.01-0.043-0.04
0000-55-109-131-328-364-444-378-503-781-594-1,113-1,190
0.030.10.151.670.260.51.581.351.652.553.182.564.44.956.926.16
9.210.29.6-24.2-16.4-47.1458.3364.1365.4534.2800.41,098.41,204.71,244.71,555.81,134.15
0000000000000000

Byhealth Co stock margins

The Byhealth Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Byhealth Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Byhealth Co.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Byhealth Co's sales revenue. A higher gross margin percentage indicates that the Byhealth Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Byhealth Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Byhealth Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Byhealth Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Byhealth Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Byhealth Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Byhealth Co Margin History

Byhealth Co Gross marginByhealth Co Profit marginByhealth Co EBIT marginByhealth Co Profit margin
2026e68.76 %18.94 %10.82 %
2025e68.76 %23.8 %10.29 %
2024e68.76 %22.29 %8.61 %
202368.76 %21.03 %18.56 %
202268.12 %21.11 %17.63 %
202165.81 %25.38 %23.6 %
202062.67 %22.96 %25.01 %
201965.37 %22.81 %-6.81 %
201867.18 %25.14 %22.97 %
201766.94 %24.4 %24.52 %
201664.11 %24.13 %23.18 %
201566.17 %28.13 %28.05 %
201464.9 %29.94 %29.48 %
201364.65 %31.62 %28.45 %
201263.3 %27.71 %26.29 %
201163.02 %27.69 %28.33 %
201063.51 %30.71 %26.61 %
200962.2 %30 %25.43 %
200859.41 %25.58 %18.82 %
200753.81 %25.71 %18.09 %

Byhealth Co Stock Sales Revenue, EBIT, Earnings per Share

The Byhealth Co earnings per share therefore indicates how much revenue Byhealth Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Byhealth Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Byhealth Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Byhealth Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Byhealth Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Byhealth Co Revenue, EBIT and net profit per share

DateByhealth Co Sales per ShareByhealth Co EBIT per shareByhealth Co Earnings per Share
2026e8.25 undefined0 undefined0.89 undefined
2025e7.49 undefined0 undefined0.77 undefined
2024e6.82 undefined0 undefined0.59 undefined
20235.55 undefined1.17 undefined1.03 undefined
20224.59 undefined0.97 undefined0.81 undefined
20214.45 undefined1.13 undefined1.05 undefined
20203.86 undefined0.88 undefined0.96 undefined
20193.48 undefined0.79 undefined-0.24 undefined
20182.97 undefined0.75 undefined0.68 undefined
20172.11 undefined0.52 undefined0.52 undefined
20161.59 undefined0.38 undefined0.37 undefined
20151.58 undefined0.44 undefined0.44 undefined
20141.3 undefined0.39 undefined0.38 undefined
20131.13 undefined0.36 undefined0.32 undefined
20120.81 undefined0.23 undefined0.21 undefined
20110.5 undefined0.14 undefined0.14 undefined
20100.35 undefined0.11 undefined0.09 undefined
20090.24 undefined0.07 undefined0.06 undefined
20080.2 undefined0.05 undefined0.04 undefined
20072.14 undefined0.55 undefined0.39 undefined

Byhealth Co business model

Byhealth Co Ltd is a company that specializes in the manufacture and sale of dietary supplements and health products. The company was founded in 1998 in Guangzhou, China. The founder of Byhealth, Mr. Liang Guangwei, has early on specialized in the production of high-quality health products and cosmetics. As a result, Byhealth quickly became a leading company in the dietary supplement industry. The company enjoys a very good reputation, particularly in Asia, and has received multiple awards. The goal of Byhealth is to offer high-quality dietary supplements and health products that support the health and well-being of customers. The company relies on its own research and development, which guarantees a high quality of the products. Byhealth distributes its products worldwide, particularly in Asia, Europe, and North America. The company works closely with distribution partners to reach a wide customer base. To achieve this, Byhealth has developed a variety of product lines tailored to different customer needs. These include products to support the immune system, digestion, sleep, skin, metabolism, and weight loss. Byhealth pays special attention to its product line Revotropix, which is among the most well-known and popular in the industry. The products contain a variety of plant-based and natural ingredients that are supposed to alleviate symptoms of stress, pain, and depression. The products are available in various forms, such as capsules or powder. Another important area is weight loss products, which are intended to help customers control and reduce their weight. These include fat-binding tablets and products that stimulate metabolism. Byhealth strictly adheres to the highest quality standards in the production of its products. All products are produced in accordance with Good Manufacturing Practice (GMP) and other international standards. The company uses only natural ingredients to ensure that all products are safe and effective. As an innovative company, Byhealth also relies on new technologies and trends to further improve its products. For example, the company uses the latest technology for the extraction of natural ingredients to ensure a higher efficacy and purity of its products. Overall, Byhealth has earned an excellent reputation in the industry with its high-quality dietary supplements and health products. Through its research and development and the use of state-of-the-art production methods, Byhealth is able to offer a wide range of health products that help customers improve their health and well-being. Byhealth Co is one of the most popular companies on Eulerpool.com.

Byhealth Co SWOT Analysis

Strengths

Byhealth Co Ltd possesses several strengths that contribute to its success in the market. Firstly, the company has a diverse portfolio of high-quality products, including nutritional supplements, personal care items, and healthcare devices. This extensive range enables Byhealth to cater to a wide target audience and capitalize on various market segments.

Secondly, Byhealth has established strong brand recognition and reputation, both domestically and internationally. The company prides itself on manufacturing products that meet stringent quality standards and are backed by extensive research and development efforts. This brand reputation helps Byhealth gain customer trust and loyalty.

Additionally, Byhealth benefits from a well-developed distribution network and strategic partnerships with retailers. This allows the company to reach a broad customer base efficiently and expand its market presence.

Weaknesses

Despite Byhealth's strengths, there are some areas where the company faces challenges. One weakness is its dependency on a few key suppliers for raw materials. Any disruption or issues with these suppliers may impact the company's production and supply chain, leading to potential delays and increased costs.

Another weakness lies in Byhealth's limited geographical diversification. The company primarily operates in a few select markets, making it susceptible to regional economic fluctuations and regulatory changes. Expanding into new markets could help mitigate this weakness.

Opportunities

Byhealth has several opportunities to explore for future growth. Firstly, the increasing global demand for health and wellness products presents a favorable market environment. Byhealth can focus on innovative product development and capitalize on emerging trends to capture a larger market share.

Moreover, Byhealth can consider expanding its online presence and e-commerce capabilities. With the rise of digital platforms, selling directly to consumers online can enhance accessibility and create additional revenue streams.

Threats

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Byhealth Co Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Byhealth Co historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Byhealth Co shares outstanding

The number of shares was Byhealth Co in 2023 — This indicates how many shares 1.695 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Byhealth Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Byhealth Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Byhealth Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Byhealth Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Byhealth Co stock splits

In Byhealth Co's history, there have been no stock splits.

Byhealth Co dividend history and estimates

In 2023, Byhealth Co paid a dividend amounting to 0.18 CNY. Dividend means that Byhealth Co distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Byhealth Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Byhealth Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Byhealth Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Byhealth Co Dividend History

DateByhealth Co Dividend
2026e0.19 undefined
2025e0.19 undefined
2024e0.19 undefined
20230.18 undefined
20220.7 undefined
20210.7 undefined
20200.36 undefined
20190.5 undefined
20180.33 undefined
20170.26 undefined
20160.3 undefined
20150.25 undefined
20140.25 undefined
20130.1 undefined
20120.08 undefined
20110.04 undefined

Byhealth Co dividend payout ratio

In 2023, Byhealth Co had a payout ratio of 63.53%. The payout ratio indicates the percentage of the company's profits that Byhealth Co distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Byhealth Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Byhealth Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Byhealth Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Byhealth Co Payout Ratio History

DateByhealth Co Payout ratio
2026e69.93 %
2025e74.05 %
2024e72.21 %
202363.53 %
202286.42 %
202166.67 %
202037.5 %
2019-208.33 %
201847.83 %
201750 %
201681.08 %
201556.82 %
201465.79 %
201331.25 %
201239.67 %
201129.79 %
201063.53 %
200963.53 %
200863.53 %
200763.53 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Byhealth Co.

Byhealth Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20230.13 0.21  (66.27 %)2023 Q3
6/30/20230.23 0.3  (29.14 %)2023 Q2
3/31/20230.51 0.61  (20.79 %)2023 Q1
12/31/20220.1 -0.06  (-157.62 %)2022 Q4
9/30/20220.24 0.25  (3.14 %)2022 Q3
6/30/20220.31 0.23  (-26.54 %)2022 Q2
3/31/20220.4 0.39  (-3.48 %)2022 Q1
12/31/2021-0.07 0.05  (176.73 %)2021 Q4
9/30/20210.15 0.16  (5.61 %)2021 Q3
6/30/20210.26 0.33  (25.67 %)2021 Q2
1
2
3

Eulerpool ESG Scorecard© for the Byhealth Co stock

Eulerpool World ESG Rating (EESG©)

60/ 100

🌱 Environment

60

👫 Social

78

🏛️ Governance

42

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees54
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Byhealth Co shareholders

%
Name
Stocks
Change
Date
63.77472 % Liang (Yunchao)710,611,74206/30/2024
4.98312 % Sun (Huigang)55,524,52606/30/2024
3.06987 % Shanghai Zhongping Guoyu Asset Management Co., Ltd.34,206,11806/30/2024
2.27231 % Bank of Communications Schroder Fund Management Co., Ltd.25,319,247-1,274,2006/30/2024
1.80615 % E Fund Management Co. Ltd.20,125,127-449,4006/30/2024
1.70929 % Qilu Zhongtai Private Placement No. 2 Private Equity Fund19,045,80106/30/2024
1.59461 % Chen (Hong)17,768,00006/30/2024
1.54648 % Liang (Shuisheng)17,231,66606/30/2024
1.20296 % Huang (Kun)13,404,00006/30/2024
1.09749 % China Southern Asset Management Co. Ltd.12,228,767285,2006/30/2024
1
2
3
4
5
...
10

Byhealth Co Executives and Management Board

Mr. Shuisheng Liang(57)
Byhealth Co Vice Chairman of the Board (since 2008)
Compensation 3.11 M
Mr. Liangping Cai(49)
Byhealth Co Chief Operating Officer, Deputy General Manager
Compensation 3 M
Mr. Zhicheng Lin(55)
Byhealth Co General Manager, Director (since 2012)
Compensation 3 M
Mr. Hong Chen(55)
Byhealth Co Deputy General Manager (since 2008)
Compensation 3 M
Mr. Hui Tang(54)
Byhealth Co Director (since 2008)
Compensation 2.99 M
1
2
3

Byhealth Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,870,840,230,18-0,37-0,08
SupplierCustomer0,820,880,910,86-0,060,12
SupplierCustomer0,780,800,740,68-0,27-0,45
SupplierCustomer0,690,770,710,400,54-0,02
SupplierCustomer0,610,71-0,140,200,020,34
SupplierCustomer0,59-0,070,38-0,100,080,29
SupplierCustomer0,400,480,820,860,720,65
SupplierCustomer0,010,530,800,790,580,59
Alibaba Group Holding Stock
Alibaba Group Holding
SupplierCustomer-0,220,420,580,480,83
SupplierCustomer-0,390,090,460,300,870,05
1

Most common questions regarding Byhealth Co

What values and corporate philosophy does Byhealth Co represent?

Byhealth Co Ltd is a leading company in the health and wellness industry. With a strong commitment to improving people's well-being, Byhealth Co Ltd values integrity, innovation, and customer satisfaction. The company's corporate philosophy revolves around delivering high-quality products and services that promote a healthy lifestyle. Byhealth Co Ltd strives to provide customers with trustworthy and reliable solutions that address their unique health needs. With a focus on research and development, the company aims to stay at the forefront of the industry, continually improving its offerings to meet the evolving demands of its customers.

In which countries and regions is Byhealth Co primarily present?

Byhealth Co Ltd is primarily present in China.

What significant milestones has the company Byhealth Co achieved?

Byhealth Co Ltd has achieved significant milestones in its journey. The company has successfully expanded its product portfolio, increased its market presence, and achieved substantial revenue growth over the years. Byhealth Co Ltd has also been recognized for its commitment to innovation and has received numerous awards for its groundbreaking products. Additionally, the company has formed strategic partnerships with key players in the industry, enhancing its global reach and market share. Byhealth Co Ltd continues to demonstrate strong performance and remains focused on delivering high-quality healthcare solutions to its customers.

What is the history and background of the company Byhealth Co?

Byhealth Co Ltd is a leading company in the healthcare industry. Established in [year], it has a rich history and a strong background. Byhealth Co Ltd focuses on research, development, and manufacturing of a wide range of medical and healthcare products. With a commitment to innovation and quality, the company has become a trusted name in the market. Byhealth Co Ltd is dedicated to improving people's lives through its advanced healthcare solutions, catering to various needs globally. With years of expertise and a customer-centric approach, Byhealth Co Ltd continues to deliver groundbreaking products in the healthcare sector.

Who are the main competitors of Byhealth Co in the market?

The main competitors of Byhealth Co Ltd in the market include Beijing Tongrentang Co Ltd, Joincare Pharmaceutical Group Industry Co Ltd, and Quanjian Group Co Ltd.

In which industries is Byhealth Co primarily active?

Byhealth Co Ltd is primarily active in the healthcare and pharmaceutical industries.

What is the business model of Byhealth Co?

Byhealth Co Ltd is a renowned company that operates in the healthcare industry. Their business model revolves around manufacturing and distributing a wide range of health products and nutritional supplements. Byhealth Co Ltd focuses on providing high-quality and innovative solutions to improve people's well-being. With a strong emphasis on research and development, they strive to constantly bring new and effective products to the market. Byhealth Co Ltd's commitment to enhancing health through their diverse product offerings has made them a trusted name in the industry.

What is the P/E ratio of Byhealth Co 2024?

The Byhealth Co P/E ratio is 33.43.

What is the P/S ratio of Byhealth Co 2024?

The Byhealth Co P/S ratio is 2.88.

What is the Quality Investing of Byhealth Co?

The Quality Investing for Byhealth Co is 7/10.

What is the revenue of Byhealth Co 2024?

The expected Byhealth Co revenue is 7.6 B CNY.

How high is the profit of Byhealth Co 2024?

The expected Byhealth Co profit is 653.66 M CNY.

What is the business model of Byhealth Co

The company Byhealth Co Ltd is a leading company specializing in the production and sale of health and wellness products. The company is headquartered in China and operates worldwide. Byhealth Co Ltd is committed to improving people's health and enabling them to live a better life. Byhealth Co Ltd has various business areas, including the development and sale of dietary supplements, natural remedies, cosmetics, and medical devices. The company harnesses advanced technologies and knowledge in the field of modern science and medical research to develop high-quality products. In the area of dietary supplements, Byhealth Co Ltd offers a variety of products including vitamins, minerals, proteins, herbal extracts, and superfoods. These products are ideal for people who want to supplement and support their diet to achieve optimal well-being. Byhealth Co Ltd only uses scientifically proven and health-supporting ingredients. Byhealth Co Ltd also has a wide range of natural remedies based on the principles of traditional Chinese medicine. These products are made from natural ingredients such as minerals, plant extracts, and other natural substances. They are used to promote physical and mental health and alleviate diseases and discomfort. The cosmetics line of Byhealth Co Ltd includes products based on the principles of naturopathy. The products are free from synthetic chemicals and are made solely from natural ingredients. The cosmetics are ideal for individuals who value chemical-free skincare and desire natural beauty. Byhealth Co Ltd also produces medical devices and instruments that can be used for the diagnosis and treatment of various diseases. These products meet high quality and safety standards and are highly reliable due to their accuracy and effectiveness. In conclusion, Byhealth Co Ltd is a leading company in the health and wellness industry. Through its wide range of products and services, the company enables people to lead better lives. With its focus on research and development, high quality, and sustainability, Byhealth Co Ltd is a trusted partner for its customers worldwide.

What is the Byhealth Co dividend?

Byhealth Co pays a dividend of 0.7 CNY distributed over payouts per year.

How often does Byhealth Co pay dividends?

The dividend cannot currently be calculated for Byhealth Co or the company does not pay out a dividend.

What is the Byhealth Co ISIN?

The ISIN of Byhealth Co is CNE100000Y84.

What is the Byhealth Co ticker?

The ticker of Byhealth Co is 300146.SZ.

How much dividend does Byhealth Co pay?

Over the past 12 months, Byhealth Co paid a dividend of 0.18 CNY . This corresponds to a dividend yield of about 1.4 %. For the coming 12 months, Byhealth Co is expected to pay a dividend of 0.19 CNY.

What is the dividend yield of Byhealth Co?

The current dividend yield of Byhealth Co is 1.4 %.

When does Byhealth Co pay dividends?

Byhealth Co pays a quarterly dividend. This is distributed in the months of May, May, May, May.

How secure is the dividend of Byhealth Co?

Byhealth Co paid dividends every year for the past 16 years.

What is the dividend of Byhealth Co?

For the upcoming 12 months, dividends amounting to 0.19 CNY are expected. This corresponds to a dividend yield of 1.44 %.

In which sector is Byhealth Co located?

Byhealth Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Byhealth Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Byhealth Co from 4/22/2024 amounting to 0.9 CNY, you needed to have the stock in your portfolio before the ex-date on 4/22/2024.

When did Byhealth Co pay the last dividend?

The last dividend was paid out on 4/22/2024.

What was the dividend of Byhealth Co in the year 2023?

In the year 2023, Byhealth Co distributed 0.7 CNY as dividends.

In which currency does Byhealth Co pay out the dividend?

The dividends of Byhealth Co are distributed in CNY.

All fundamentals about Byhealth Co

Our stock analysis for Byhealth Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Byhealth Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.